Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes today touted results from a systemic review of prospective studies comparing postoperative outcomes of both anterior and posterior approaches to total hip arthroplasty procedures. Results from the study, which were published in The Journal of Arthroplasty, indicated that the anterior approach results in increases in hip function and reduction in […]
Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
🎙️ Tune in to the Ortho Innovation Talks podcast on the DeviceTalks podcast network.
Latest Orthopedics News
Zimmer Biomet moves Puerto Rican workers to Indiana
In the wake of the devastation left by Hurricane Maria in Puerto Rico, Zimmer Biomet (NYSE:ZBH) is sending dozens of its employees from the island to northeast Indiana. Large portions of Puerto Rico remain without electricity and medical device companies have struggled in the last few months to get their facilities back up and running at full […]
IlluminOss Medical wins de novo nod from FDA for bone stabilization system
The FDA last month granted de novo clearance to the photodynamic bone stabilization system developed by IlluminOss Medical. The IlluminOss device uses a light-curable polymer, delivered in an expandable balloon catheter, to stabilize bone fractures. In a Dec. 19 letter to the East Providence, R.I.-based company, the FDA granted de novo clearance for an indication for […]
7 medtech stories we missed this week: Jan. 19, 2018
From Privi Medical’s FDA clearance to OrthoXel getting FDA clearance and CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Privi Medical wins FDA nod for hemorrhoid device Privi Medical has received FDA clearance for its Instalief Hemorrhoids Treatment device, according to a Jan. 18 news […]
Centinel Spine reports $132m funding round
Fresh from its acquisition of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes’ Prodisc assets, Centinel Spine last week reported raising more than $132 million. In the waning days of 2017, Centinel it closed its acquisition of DePuy’s Prodisc-C, Prodisc-L, Prodisc-C Vivo, Prodisc-C Nova, Prodisc-O and Discover cervical and lumbar artificial disc systems. Although the purchase price remained undisclosed, Centinel said at […]
Smith & Nephew touts lower readmission rates for bundled joint procedure packages
Smith & Nephew (NYSE:SNN) is touting a 97.3% decrease in readmission rates for joint arthroplasties using its Episode of Care Assurance Program, a bundled payment option designed to reward good patient outcomes. Working with group purchasing organization Provider PPI, the British orthopedics and wound care giant’s eCAP program combines its hip and knee implants, Pico negative-pressure wound […]
Revision rates prompt recalls for Johnson & Johnson’s DePuy Synthes, Zimmer Biomet
High revision rates for orthopedic implants prompted recalls in recent months for Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes and Zimmer Biomet (NYSE:ZBH). Last month DePuy Synthes recalled a stand-alone element of its Sigma HP partial knee replacement, the Sigma HP PFJ cemented trochlear implant, “based on elevated revision rates observed as part of the company’s post-market surveillance […]
Boston Scientific touts spinal cord stim pain-relief trial
Boston Scientific (NYSE:BSX) touted data today from a trial evaluating spinal cord stimulation therapy in patients seeking pain relief. The Whisper trial showed that patients who are given the choice to use both sub-perception and paresthesia-based spinal cord stimulation therapy experience better outcomes compared to patients who have just one spinal cord stimulation therapy option. In […]
RTI Surgical buys Zyga Tech and its SImmetry sacroiliac fusion device, updates 2018 outlook
RTI Surgical (NSDQ:RTIX) yesterday announced an agreement to purchase Zyga Technology and its SImmetry sacroiliac joint fusion system and today released updated guidance for 2018 and beyond. The Alachua, Fla.-based RTI surgical said that Zyga Technology has approximately 30 employees and $4 million in annual revenue, and that it plans to fund the acquisition through a combination […]
NuVasive wins expanded FDA nod, launches interbody fusion devices
NuVasive Inc. (NSDQ:NUVA) said today it won expanded FDA 510(k) clearance for its Cohere cervical interbody fusion device and that it launched the Coalesce thoracolumbar interbody fusion device. Both the launch and updated clearance comes from the company’s acquisition of Vertera Spine, which it closed last September. The Cohere and Coalesce implants use porous version of the material […]
Zimmer Biomet wins FDA nod for Sidus stem-free shoulder system
Zimmer Biomet (NYSE:ZBH) said today it won FDA clearance for its Sidus stem-free shoulder system. The newly cleared Sidus system is designed as a total shoulder arthroplasty solution for patients with good bone stock with either osteoarthritis, post-traumatic arthrosis, focal avascular necrosis of the humeral head or those who’ve had previous surgeries of the shoulder that […]